News
Read our latest updates from research breakthroughs to government actions to fundraising heroes. You can also read personal stories from women and their families directly affected by ovarian cancer.
Unlocking the power of the immune system
Target Ovarian Cancer's new project represents a new frontier in ovarian cancer research.
It's time to TAKE OVAR - one year on
This time last year, we launched our ‘It’s time to TAKE OVAR’ campaign. The campaign aims to transform the futures of more than 25,000 women in the UK who are living with ovarian cancer – and thousands more who are yet to be diagnosed.
NICE is consulting on ovarian cancer drug olaparib (Lynparza®)
Today, the National Institute for Health and Care Excellence (NICE) has published some draft guidance about ovarian cancer drug olaparib (Lynparza®).
We now know the UK trails other countries in early ovarian cancer diagnosis
Today sees the release of a global study from the World Ovarian Cancer Coalition. Among other things, it shows us that women in the UK are being failed when it comes to early diagnosis of ovarian cancer in comparison with other countries.
Women cannot wait for speedier diagnosis of ovarian cancer
Rebecca Rennison, Target Ovarian Cancer’s Director of Public Affairs and Services, has been working to make sure NHS England’s new approach to speedier diagnosis works for women with ovarian cancer.
Ask the Experts Conference 2018 Roundup
Thursday, 13 September saw over 100 women with ovarian cancer and their family and friends join specialist doctors, surgeons, and researchers for Target Ovarian Cancer’s third Ask the Experts Conference at the University of Reading.
